World's Best Scientists 2026 revealed!
Anna Ludovica Fracanzani

Anna Ludovica Fracanzani

D-Index & Metrics

Medicine

D-Index
80
Citations
18871
World Ranking
17303
National Ranking
698

Overview

Anna Ludovica Fracanzani is affiliated with the University of Milan in Italy and primarily works within the field of Medicine. Their research spans several subfields, notably Epidemiology, Hepatology, Molecular Biology, Endocrinology, Diabetes and Metabolism, and Surgery.

The scientist's research focuses on topics related to liver diseases, including diagnosis and treatment as well as transplantation. Other significant areas of study include Hepatitis C virus research, endoplasmic reticulum stress and disease, diet, metabolism and disease, COVID-19 clinical research studies, and pancreatitis pathology and treatment.

Frequent co-authors in Anna Ludovica Fracanzani's publications include:

  • Paola Dongiovanni
  • Rosa Lombardi
  • Luca Valenti
  • Marica Meroni
  • Salvatore Petta

The scientist often publishes in the following venues:

  • Digestive and Liver Disease
  • Journal of Hepatology
  • Liver International
  • Internal and Emergency Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)

Anna Ludovica Fracanzani has been involved in the publication of several studies, including:

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure (2020), New England Journal of Medicine
  • Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores (2020), Journal of Hepatology
  • Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial (2021), Nature Medicine
  • Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? (2021), Gut
  • Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease (2021), Journal of Hepatology

Best Publications

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

    David Ellinghaus;Frauke Degenhardt;Luis Bujanda;Maria Buti

  • Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

    Anna Ludovica Fracanzani;Luca Valenti;Elisabetta Bugianesi;Marco Andreoletti

  • Homozygosity for the patatin-like phospholipase-3/adiponutrin i148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

    Luca Valenti;Ahmad Al-Serri;Ann K. Daly;Enrico Galmozzi

  • Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

    Paola Dongiovanni;Salvatore Petta;Cristina Maglio;Anna Ludovica Fracanzani

  • Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

    Luca Valenti;Anna Ludovica Fracanzani;Paola Dongiovanni;Gennaro Santorelli

  • Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target

    Paola Dongiovanni;Anna Ludovica Fracanzani;Silvia Fargion;Luca Valenti

  • Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.

    Silvia Fargion;Alberto Piperno;Maria Domenica Cappellini;Maurizio Sampietro

  • Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

    Luca Valenti;Anna Ludovica Fracanzani;Paola Dongiovanni;Elisabetta Bugianesi

  • Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.

    Silvia Fargion;Michela Mattioli;Anna Ludovica Fracanzani;Maurizio Sampietro

  • HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.

    Luca Valenti;Anna Ludovica Fracanzani;Elisabetta Bugianesi;Paola Dongiovanni

  • Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease

    Anna Ludovica Fracanzani;Larry Burdick;Sara Raselli;Paola Pedotti

  • Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron-related chronic liver disease

    Anna Ludovica Fracanzani;Dario Conte;Mirella Fraquelli;Emanuela Taioli

  • Patatin‐Like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

    Luca Valenti;MariaGrazia Rumi;Enrico Galmozzi;Alessio Aghemo

  • Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis.

    Silvia Fargion;Clara Mandelli;Alberto Piperno;Bruno Cesana

  • Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development

    Mauro Borzio;Silvia Fargion;Franco Borzio;Anna Ludovica Fracanzani

  • Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.

    Cristiana Bianco;Oveis Jamialahmadi;Serena Pelusi;Serena Pelusi;Guido Baselli

  • Nonalcoholic fatty liver disease and vascular disease: State-of-the-art

    Silvia Fargion;Marianna Porzio;Anna Ludovica Fracanzani

  • MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

    Benedetta Donati;Paola Dongiovanni;Stefano Romeo;Stefano Romeo;Marica Meroni

  • Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.

    P Dongiovanni;L Valenti;R Rametta;A K Daly

  • High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.

    Maurizio Sampietro;Alberto Piperno;Loredana Lupica;Cristina Arosio

Frequent Co-Authors

Luca Valenti
Luca Valenti University of Milan
Silvia Fargion
Silvia Fargion University of Milan
Salvatore Petta
Salvatore Petta University of Palermo
Stefano Romeo
Stefano Romeo University of Gothenburg
Elisabetta Bugianesi
Elisabetta Bugianesi University of Turin
Antonio Craxì
Antonio Craxì University of Palermo
Quentin M. Anstee
Quentin M. Anstee Newcastle University
Maria Domenica Cappellini
Maria Domenica Cappellini University of Milan
Calogero Cammà
Calogero Cammà University of Palermo
Flora Peyvandi
Flora Peyvandi University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring healthcare careers beyond traditional medical school, a wide range of flexible online degrees may fit your goals. Programs like online mha programs cahme accredited offer advanced training in healthcare administration, preparing graduates for leadership roles in hospitals and healthcare systems while ensuring nationally recognized standards.

Nursing professionals can benefit from bridge programs designed for flexibility. Options such as rn to bsn online programs without clinicals allow registered nurses to earn their bachelor’s degree conveniently, bypassing the need for additional in-person clinical hours.

For those pursuing advanced nursing roles, consider online dnp programs to quickly earn a Doctor of Nursing Practice and expand your clinical expertise or leadership credentials. There are also easiest dnp program online options for working professionals seeking an accessible route to doctoral qualifications.

Whether you are interested in administration, nursing leadership, or expanding your scope of practice, these online healthcare degree pathways can open new doors and support a diverse range of medical careers.

Best Scientists Citing Anna Ludovica Fracanzani

Trending Scientists